Villers-la-Ville, Belgium

Françoise Lurquin



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Françoise Lurquin: Innovator in Chemical Processes**

Introduction

Françoise Lurquin is an accomplished inventor based in Villers-la-Ville, Belgium. He has made significant contributions to the field of chemistry, particularly in the preparation of complex chemical compounds. With a total of two patents to his name, his work has garnered attention within the scientific community.

Latest Patents

Lurquin's recent innovations include two notable patents related to 2-oxo-1-pyrrolidine derivatives. The first patent presents a new process for preparing these derivatives of general formula (I), with specific substituents as defined in the respective specifications. The second patent focuses on a similar theme but emphasizes the cyclisation of an intermediate of general formula (II) via intramolecular allylation, showcasing his expertise in chemical synthesis and innovation.

Career Highlights

Françoise Lurquin is associated with UCB Pharma, a leading biopharmaceutical company. His work in this dynamic environment allows him to apply his innovative ideas to real-world applications, potentially leading to breakthroughs in medication and therapeutic solutions.

Collaborations

Throughout his career, Lurquin has collaborated with talented colleagues, including renowned scientists such as John Surtees and Ousmane Diouf. These collaborations exemplify the importance of teamwork in scientific research and innovation, leading to the exchange of ideas and shared advancements in their respective fields.

Conclusion

Françoise Lurquin continues to make strides in the realm of chemical innovations through his patents and collaborations. His dedication to advancing chemical processes solidifies his reputation as a key inventor in the industry, providing significant contributions to the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…